Shubham Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 16-11-2024
- Paid Up Capital ₹ 1.57 Cr
as on 16-11-2024
- Company Age 32 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 47.94 Cr
as on 16-11-2024
- Satisfied Charges ₹ 47.60 Cr
as on 16-11-2024
- Revenue -5.01%
(FY 2023)
- Profit -7.10%
(FY 2023)
- Ebitda -12.60%
(FY 2023)
- Net Worth 25.55%
(FY 2023)
- Total Assets 8.76%
(FY 2023)
About Shubham Pharmachem
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.57 Cr.
The company currently has active open charges totaling ₹47.94 Cr. The company has closed loans amounting to ₹47.60 Cr, as per Ministry of Corporate Affairs (MCA) records.
Manish Jajodia, Jaya Jajodia, and Ashish Jajodia serve as directors at the Company.
- CIN/LLPIN
U99999MH1992PTC065071
- Company No.
065071
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jan 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Shubham Pharmachem?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manish Jajodia  | Director | 15-Jan-1993 | Current |
| Jaya Jajodia | Director | 01-Jul-2015 | Current |
| Ashish Jajodia | Director | 15-Jan-1993 | Current |
Financial Performance and Corporate Structure Insights of Shubham Pharmachem.
Shubham Pharmachem Pvt Ltd, for the financial year ended 2023, experienced Minor drop in revenue, with a 5.01% decrease. The company also saw a slight decrease in profitability, with a 7.1% decrease in profit. The company's net worth Soared by an impressive increase of 25.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shubham Pharmachem?
In 2023, Shubham Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Smick Laboratories Private LimitedActive 10 years 4 monthsManish Jajodia and Ashish Jajodia are mutual person
Anzen Exports Private LimitedActive 17 years 4 monthsManish Jajodia and Ashish Jajodia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Sep 2024 | ₹3.30 M | Open |
Others Creation Date: 12 Jul 2024 | ₹15.50 Cr | Open |
Others Creation Date: 21 May 2024 | ₹2.50 Cr | Open |
How Many Employees Work at Shubham Pharmachem?
Shubham Pharmachem has a workforce of 30 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shubham Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shubham Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
